Clinical Trial

MR 7700 Multinuclear Application Clinical Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 26, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this clinical study is to perform phosphorus nucleus (31P) and sodium nucleus (23Na) imaging of the liver in patients with primary hepatocellular carcinoma (HCC) and healthy volunteers using the MR 7700 Magnetic Resonance Equipment, in order to explore the manifestations of multinuclear imaging in HCC patients and healthy volunteers.
Trial Details
NCT Number NCT07368049
Lead Sponsor Philips Clinical & Medical Affairs Global
Conditions Hepatocellular Carcinoma, MRI
Enrollment 100 participants
Start Date 2026-01-05
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-26